Skip to content
RDL Network logo
TCT-619 ABSORB Cohort B Trial: Five Year Angiographic Results Of The ABSORB Everolimus Eluting Bioresorbable Vascular Scaffold — Bernard De Bruyne (2014) | RDL Network